Skip to main content
Alexander Fay, MD, Neurology, San Francisco, CA

Alexander James Fay MD PhD

Neuromuscular Medicine, Child Neurology


Associate Professor

Request Appointment
  • Department if Neurology1825 4th Street, 5th Floor, 5ASan Francisco, CA 94143

  • Book by Phone+1(833) 802-0951

  • Fax+1 415-353-2400

Overview of  Dr. Fay

Dr. Alexander Fay is a neurologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and UCSF Benioff Children's Hospital Oakland. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 7 years. He is one of 305 doctors at UCSF Medical Center and one of 9 doctors at UCSF Benioff Children's Hospital Oakland who specialize in Neurology. He has more than 10 publications and over 500 citings.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 2012 - 2015
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2010 - 2012
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2026
  • MO State Medical License
    MO State Medical License 2015 - 2017
  • Neurology with Special Qualification in Child Neurology
    American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • Neuromuscular Medicine
    American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

Press Mentions

  • Roche’s SMA Therapy Faces Uphill Struggle Against Spinraza
    Roche’s SMA Therapy Faces Uphill Struggle Against SpinrazaAugust 6th, 2019
  • Muscular Dystrophy Association Celebrates FDA Approval of Argenx’s Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia Gravis
    Muscular Dystrophy Association Celebrates FDA Approval of Argenx’s Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia GravisJune 22nd, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: